Please login to the form below

Not currently logged in
Email:
Password:

Functional genomics

This page shows the latest Functional genomics news and features for those working in and with pharma, biotech and healthcare.

GSK joins forces with Doudna’s CRISPR lab

GSK joins forces with Doudna’s CRISPR lab

Doudna and Weissman will be members of the steering committee, together with GSK’s new head of functional genomics, Chris Miller, who just joined GSK from AbbVie. ... A similar long-term partnership in functional genomics was unveiled by AstraZeneca

Latest news

  • Gilead drives NASH development with insitro collaboration Gilead drives NASH development with insitro collaboration

    To do this, insitro will utilise its Human (ISH) platform, which applies machine learning, human genetics and functional genomics to generate in vitro models and drive therapeutic discovery and development.

  • GSK and Sanofi join Finland's 500,000 genomics study GSK and Sanofi join Finland's 500,000 genomics study

    AstraZeneca, MSD and Pfizer already participating. GlaxoSmithKline and Sanofi have joined academic groups and other pharma companies to take part in Finland’s large scale genomics project, based on data from

  • AZ and CRUK launch Cambridge genomics centre AZ and CRUK launch Cambridge genomics centre

    Based at the University of Cambridge’s Milner Therapeutics Institute, The Functional Genomics Centre will be just 10 minutes away from AstraZeneca’s new headquarters and the CRUK institute, and will ... The new partnership representation an expansion

  • The virtual patient

    ITFoM has the ambitious goal of bringing together medicine and state-of-the-art diagnostic techniques such as medical imaging and functional genomics, virtual patient models and new data handling tools ... ITFoM has the ambitious goal of bringing

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Cutting through the noise: CRISPR Cutting through the noise: CRISPR

    AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery. ... The company has invested heavily in CRISPR and the broader functional genomics platform, and its upcoming move to Cambridge will be

  • Deal Watch October 2018

    treatments based on functional genomics discovery. platform. Strategic. collaboration. $1.75B. SQZ Biotech/. ... Gilead has paid $50m upfront to gain access to Tango’s functional genomics‐based discovery platform, for which it has options on up to

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Novasecta

We are a specialist strategy consulting firm for pharmaceutical and biotech companies. We help our clients to achieve significant performance...

Latest intelligence

RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...
What do Healthcare Professionals think about the inclusion of remote selling techniques?
Evolving to a digitally focused pharma / healthcare company - an organisational roadmap...
Drug pricing and competition
Strengthening business competition and reducing anti-competitive practices
How the CMA is tackling high prices for essential drugs...

Infographics